A small molecule activator of AKT does not reduce ischemic injury of the rat heart

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Moreira, Jose B N ^a,b   Wohlwend, Martin ^a   Alves, Marcia N M ^a   Wisløff, Ulrik ^a   Bye, Anja ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Norwegian Council on Cardiovascular Disease   (Norway)

Author keywords

Apoptosis; Cardioprotection; Infarction; Ischemia; Preconditioning

Indexed keywords

ADENOSINE TRIPHOSPHATE; BIOLOGICAL MARKER; CASPASE 3; CREATINE KINASE; CYTOCHROME C; ENZYME ACTIVATOR; LACTATE DEHYDROGENASE; MITOCHONDRIAL ENZYME; PROTEIN KINASE B; SC 79; UNCLASSIFIED DRUG; MOLECULAR LIBRARY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; DRUG EFFICACY; ENZYME ACTIVATION; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; RAT; REPERFUSION INJURY; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE; DRUG EFFECTS; ENZYMOLOGY; HEART INFARCTION; METABOLISM; MITOCHONDRION; MOLECULAR LIBRARY; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PATHOLOGY; PHARMACOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; APOPTOSIS; CREATINE KINASE; ENZYME ACTIVATION; ENZYME ACTIVATORS; FEMALE; MITOCHONDRIA; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; SMALL MOLECULE LIBRARIES;

EID: 84928732368     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0444-x     Document Type: Article

References (45)

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357(11):1121-35. doi 10.1056/NEJMra071667.
2. Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92-100. doi 10.1172/JCI62874.
3. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet. 1993;342(8866):276-7
4. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, et al. Postconditioning the human heart. Circulation. 2005;112(14):2143-8. doi 10.1161/CIRCULATIONAHA.105.558122.
5. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010;375(9716):727-34. doi 10.1016/S0140-6736(09)62001-8.
6. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007;370(9587):575-9. doi 10.1016/S0140-6736(07)61296-3.
7. Hausenloy DJ, Yellon DM. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res. 2006;70(2):240-53. doi 10.1016/j.cardiores.2006.01.017.
8. Mocanu MM, Bell RM, Yellon DM. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol. 2002;34(6):661-8. doi 10.1006/jmcc.2002.2006.
9. Hausenloy DJ, Iliodromitis EK, Andreadou I, Papalois A, Gritsopoulos G, Anastasiou-Nana M, et al. Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart. Cardiovasc Drugs Ther. 2012;26(2):87-93. doi doi 10.1007/s10557-011-6364-y
10. Wu QL, Shen T, Shao LL, Ma H, Wang JK. Ischemic postconditioning mediates cardioprotection via PI3K/GSK-3beta/beta-catenin signaling pathway in ischemic rat myocardium. Shock. 2012;38(2):165-9. doi 10.1097/SHK.0b013e31825b5633.
11. Kunuthur SP, Mocanu MM, Hemmings BA, Hausenloy DJ, Yellon DM. The Akt1 isoform is an essential mediator of ischaemic preconditioning. J Cell Mol Med. 2012;16(8):1739-49. doi 10.1111/j.1582-4934.2011.01491.x.
12. Slagsvold KH, Moreira JB, Rognmo O, Hoydal M, Bye A, Wisloff U, et al. Remote ischemic preconditioning preserves mitochondrial function and activates pro-survival protein kinase Akt in the left ventricle during cardiac surgery: a randomized trial. Int J Cardiol. 2014;177(2):409-17. doi 10.1016/j.ijcard.2014.09.206.
13. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000;101(6):660-7
14. Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M, et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation. 2001;104(3):330-5
15. Matsui T, Li L, Wu JC, Cook SA, Nagoshi T, Picard MH, et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem. 2002;277(25):22896-901. doi 10.1074/jbc.M200347200.
16. Jo H, Mondal S, Tan D, Nagata E, Takizawa S, Sharma AK, et al. Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death. Proc Natl Acad Sci U S A. 2012;109(26):10581-6. doi 10.1073/pnas.1202810109.
17. Bell RM, Mocanu MM, Yellon DM. Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol. 2011;50(6):940-50. doi 10.1016/j.yjmcc.2011.02.018.
18. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation. 2005;112(17):2686-95. doi 10.1161/CIRCULATIONAHA.105.554360.
19. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359(5):473-81. doi 10.1056/NEJMoa071142.
20. Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res. 2004;61(3):427-36. doi 10.1016/j.cardiores.2003.09.031.
21. Walters AM, Porter Jr GA, Brookes PS. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy. Circ Res. 2012;111(9):1222-36. doi 10.1161/CIRCRESAHA.112.265660.
22. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A. 1999;96(14):8144-9
23. Cook SA, Matsui T, Li L, Rosenzweig A. Transcriptional effects of chronic Akt activation in the heart. J Biol Chem. 2002;277(25):22528-33. doi 10.1074/jbc.M201462200.
24. Deng W, Leu HB, Chen Y, Chen YH, Epperson CM, Juang C, et al. Protein kinase B (PKB/AKT1) formed signaling complexes with mitochondrial proteins and prevented glycolytic energy dysfunction in cultured cardiomyocytes during ischemia-reperfusion injury. Endocrinology. 2014;155(5):1618-28. doi 10.1210/en.2013-1817.
25. Ceci M, Gallo P, Santonastasi M, Grimaldi S, Latronico MV, Pitisci A, et al. Cardiac-specific overexpression of E40K active Akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis. Cell Death Differ. 2007;14(5):1060-2. doi 10.1038/sj.cdd.4402095.
26. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes. 2005;54(8):2360-4
27. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, et al. Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res. 2000;86(6):692-9
28. Butler KL, Huffman LC, Koch SE, Hahn HS, Gwathmey JK. STAT-3 activation is necessary for ischemic preconditioning in hypertrophied myocardium. Am J Physiol Heart Circ Physiol. 2006;291(2):H797-803. doi 10.1152/ajpheart.01334.2005.
29. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase CIts role in ischemic preconditioning in the rat. Cir Res. 1994;75(3):586-90
30. Baxter GF. Role of adenosine in delayed preconditioning of myocardium. Cardiovasc Res. 2002;55(3):483-94
31. Sato T, Marban E. The role of mitochondrial K(ATP) channels in cardioprotection. Basic Res Cardiol. 2000;95(4):285-9
32. Yang C, Talukder MA, Varadharaj S, Velayutham M, Zweier JL. Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation. Cardiovasc Res. 2013;97(1):33-43. doi 10.1093/cvr/cvs287.
33. McNamara CR, Degterev A. Small-molecule inhibitors of the PI3K signaling network. Future Med Chem. 2011;3(5):549-65. doi 10.4155/fmc.11.12.
34. Nagoshi T, Matsui T, Aoyama T, Leri A, Anversa P, Li L, et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest. 2005;115(8):2128-38. doi 10.1172/JCI23073.
35. Su W, Wan Q, Han L, Huang J, Chen X, Chen G, et al. Doxycycline exerts multiple anti-allergy effects to attenuate murine allergic conjunctivitis and systemic anaphylaxis. Biochem Pharmacol. 2014;91(3):359-68. doi 10.1016/j.bcp.2014.08.001.
36. So EY, Ouchi T. BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunction. BMC Cancer. 2014;14:548. 10.1186/1471-2407-14-548
37. da Silva TF, Eira J, Lopes AT, Malheiro AR, Sousa V, Luoma A, et al. Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination. J Clin Invest. 2014;124(6):2560-70. doi 10.1172/JCI72063.
38. Basu S, Hubbard B, Shevach EM. Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells. J Leukoc Biol. 2015;97(2):279-83. doi doi 10.1189/jlb.2AB0514-273RR
39. Zhang RH, Guo H, Kandadi MR, Wang XM, Ren J. Ca + 2/calmodulin-dependent protein kinase mediates glucose toxicity-induced cardiomyocyte contractile dysfunction. Exp Diabetes Res. 2012;2012:829758. 10.1155/2012/829758
40. Chambers KT, Leone TC, Sambandam N, Kovacs A, Wagg CS, Lopaschuk GD, et al. Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response. J Biol Chem. 2011;286(13):11155-62. doi 10.1074/jbc.M110.217349.
41. Tong H, Chen W, London RE, Murphy E, Steenbergen C. Preconditioning enhanced glucose uptake is mediated by p38 MAP kinase not by phosphatidylinositol 3-kinase. J Biol Chem. 2000;275(16):11981-6
42. Kainulainen H, Komulainen J, Takala T, Vihko V. Effect of chronic exercise on glucose uptake and activities of glycolytic enzymes measured regionally in rat heart. Basic Res Cardiol. 1989;84(2):174-90
43. Bozi LH, Maldonado IR, Baldo MP, Silva MF, Moreira JB, Novaes RD, et al. Exercise training prior to myocardial infarction attenuates cardiac deterioration and cardiomyocyte dysfunction in rats. Clinics. 2013;68(4):549-56. doi 10.6061/clinics/2013(04)18.
44. Sambandam N, Lopaschuk GD. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog Lipid Res. 2003;42(3):238-56
45. van den Munckhof I, Riksen N, Seeger JP, Schreuder TH, Borm GF, Eijsvogels TM, et al. Aging attenuates the protective effect of ischemic preconditioning against endothelial ischemia-reperfusion injury in humans. Am J Physiol Heart Circ Physiol. 2013;304(12):H1727-32. doi 10.1152/ajpheart.00054.2013.